Pharmacoepidemiological analysis of the treatment of bronchial asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 683s Year: 2005
The effectiveness of nebulizer therapy in the treatment of patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 424s Year: 2001
Neuroregulatorial therapy of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 55s Year: 2002
Once-daily QVA149 improves dyspnoea, lung function and reduces rescue medication use in symptomatic patients with COPD using LAMA as prior medication: The BLAZE study Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014
Changes in the quality of life of pulmonary TB patients depending on the severity of bronchial obstruction when using standard antituberculosis therapy and inhaled bronchodilator therapy Source: Eur Respir J 2003; 22: Suppl. 45, 21s Year: 2003
Predictors of excessive short-acting beta2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database. Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020
Extracorporal therapy of bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 50s Year: 2001
Inhaler therapy in obstructive airways disease (OAD): prescription, compliance and technique Source: Eur Respir J 2006; 28: Suppl. 50, 57s Year: 2006
Bronchial thermoplasty benefits patients following withdrawal of LABA therapy Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010
Influence of combined antiasthmatic basic therapy on hyperinflation in patients with severe bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 553s Year: 2007
Pharmacoepidemiological analysis of the use of bronchodilators in bronchial asthma (BA) treatment in Russia Source: Eur Respir J 2007; 30: Suppl. 51, 154s Year: 2007
Efficacy of the long-term therapy with simbicort in children with bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 395s Year: 2005
Effect of QVA149 on lung function in the subgroup of patients with a history of exacerbations in the previous year and baseline ICS use from the SHINE study Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014
Cost-minimisation analysis of two different inhaled steroids in persistent bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 302s Year: 2002
Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014
Rescue/acute and allergy medication use among children on asthma controller therapy Source: Eur Respir J 2004; 24: Suppl. 48, 378s Year: 2004
Long-acting anticholinergics in the treatment of severe asthma with irreversible airway obstruction Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014
Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with moderate to severe airflow obstruction, stratified by severity Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Effects of add-on omalizumab therapy on airway wall thickening in severe persistent asthma Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011
Once-daily tiotropium respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014